ResearchIn-Press PreviewCell biologyOncology
Open Access |
10.1172/jci.insight.202414
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by Huang, C. in: PubMed | Google Scholar
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by Moorthy, S. in: PubMed | Google Scholar
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by Li, Q. in: PubMed | Google Scholar
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by Ahmed, K. in: PubMed | Google Scholar
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by Saab, K. in: PubMed | Google Scholar
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by Deng, D. in: PubMed | Google Scholar
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by Wang, J. in: PubMed | Google Scholar
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by Rao, X. in: PubMed | Google Scholar
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by Zhang, J. in: PubMed | Google Scholar
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by Xi, Y. in: PubMed | Google Scholar
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by Wang, J. in: PubMed | Google Scholar
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by Liu, Z. in: PubMed | Google Scholar
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by Tanaka, N. in: PubMed | Google Scholar
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by Wheeler, D. in: PubMed | Google Scholar
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by Shinbrot, E. in: PubMed | Google Scholar
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by Saade, R. in: PubMed | Google Scholar
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by Pickering, C. in: PubMed | Google Scholar
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by Xie, T. in: PubMed | Google Scholar
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by El-Naggar, A. in: PubMed | Google Scholar
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by Osman, A. in: PubMed | Google Scholar
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by
Rai, K.
in:
PubMed
|
Google Scholar
|
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by Zweidler-McKay, P. in: PubMed | Google Scholar
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by
Heymach, J.
in:
PubMed
|
Google Scholar
|
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by
Byers, L.
in:
PubMed
|
Google Scholar
|
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by
Johnson, F.
in:
PubMed
|
Google Scholar
|
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by Sandulache, V. in: PubMed | Google Scholar
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by Myers, J. in: PubMed | Google Scholar
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by Yadollahi, P. in: PubMed | Google Scholar
1Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, United States of America
2Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
3Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
4Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America
5Department of Otolaryngology, Lebanese American University, Beirut, Lebanon
6Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
7Department of Genomic Medicine and MDACC Epigenomics Therapy Initiative, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
8Department of Pediatric Leukemia and Lymphoma, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
9Department of Thoracic/Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, United States of America
Find articles by
Frederick, M.
in:
PubMed
|
Google Scholar
|
Published April 16, 2026 - More info
Inactivating NOTCH1 mutations in head and neck squamous cell carcinoma (HNSCC) were described over a decade ago, suggesting a tumorsuppressor function—unlike its oncogenic role in other tumors. Today, much debate persists regarding a putative oncogenic role in HNSCC as well, with reports that NOTCH1 signaling drives tumor growth and a cancerstemcell (CSC) phenotype. In this work, comprehensive experiments unequivocally demonstrate that NOTCH1 is a tumor suppressor in HNSCC regardless of mutation or activation status and that it reduces CSC frequency. We developed a signature of NOTCH1 activation showing the pathway is associated with very early differentiation, an altered tumor microenvironment, and better prognosis. Clarifying whether NOTCH1 occasionally functions as an oncogenic driver in HNSCC is crucial to prognosis and personalized therapy. The results presented unify the field, reconcile conflicting data, and provide critical insights into the biological and clinical significance of NOTCH1, with broader implications in other squamous carcinomas with NOTCH1 mutations.